QBIO News and Press, Q BioMed Inc From 07/08/20

Q BioMed ( OTCQB:QBIO +1.3% )  announced today that it entered an exclusive Named Patient Program distribution agreement with Caligor Coghlan Pharma Services for its non-opioid metastatic cancer bone pain drug, Strontium, 89. More news on: Q BioMed Inc., Healthcare stocks news R...

NEW YORK , July 8, 2020 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today it has entered into an exclusive Named Patient Program distribution agreement for its non-opioid metastatic cancer bone pain drug, Strontium89 , with Caligor Cog...

NEW YORK , June 30, 2020 /PRNewswire/ --  Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, today issued a letter to shareholders. Dear Fellow Shareholders, We are extremely pleased to have reached our initial goal of becoming a commercial pharmaceutical compan...

NEW YORK , June 12, 2020 /PRNewswire/ -- Q BioMed (OTC: QBIO) is proud to be a Supporter of the Living Beyond Breast Cancer ( LBBC ) 2020 Virtual Conference on Metastatic Breast Cancer taking place June 13 and 14, 2020. Over 1,100 patients will be participating in this virtual confere...

NEW YORK , May 15, 2020 /PRNewswire/ --  Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announces the launch of its marketing campaign for its FDA approved non-opioid metastatic bone pain drug Strontium89 (Strontium Chloride Sr-89 Injection, USP). A product websi...

NEW YORK, April 30, 2020 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and Q BioMed Inc. (OTCQB: QBIO) (the "Company"), a commercial stage biotechnology company, announced today that a new audio interview with the Company is now available. The interview featuring an overview of QBIO&...

Phoenix, Arizona--(Newsfile Corp. - April 27, 2020) - The Stock Day Podcast welcomed Q BioMed Inc. (OTCQB: QBIO) ("the Company"), a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector. CEO of the Company, D...

April 22, 2020 Palm Beach, FL – April 22, 2020  – The question heard around the world is “When will a coronavirus vaccine be ready?”. Its not an “if” but a “when” and that “when” from all accounts will most...

NEW YORK , April 22, 2020 /PRNewswire/ --  Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, today announced that together with its technology partner, Mannin Research, they are accelerating the rapid development of novel drugs for the treatment of life-threatening ...

Q BioMed ( OTCQB:QBIO ) has entered into a financial transaction with Yorkville Advisors Global (YA). More news on: Q BioMed Inc., Read more ...